Secondary
Cocrystal Pharma, Inc.
Cocrystal is a clinical stage biotechnology company seeking to discover and develop novel antiviral therapeutics as treatments for serious and/or chronic viral diseases.
Symbol
COCP
Last Closing Price
$1.90
Anticipated Date
TBD
Underwriters
A.G.P.
To view the prospectus for Cocrystal Pharma, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277